SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 10,891.43 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 4,181.80 |
| Book Value / Share | 50.87 |
| Price / Book | n/a |
| NCAV ($M) | 0.00 |
| NCAV / Share | 0.00 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.07 |
| Return on Assets (ROA) | 0.05 |
| Return on Equity (ROE) | 0.09 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | -0.19 |
| Current Ratio | 1.34 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 0.00 |
| Assets | 6,439.00 |
| Liabilities | 0.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 3,574.50 |
| Operating Income | 791.60 |
| Net Income | 345.90 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 915.50 |
| Cash from Investing | -676.60 |
| Cash from Financing | -100.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| IOFNF – Iofina plc | IPHYF – Innate Pharma S.A. |
| IPIX – Innovation Pharmaceuticals Inc. | ISCO – International Stem Cell Corporation |
| IVBT – Innovation1 Biotech Inc. |
Financial data and stock pages provided by
Fintel.io